Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb 15;361(2):218-25.
doi: 10.1016/j.ab.2006.11.011. Epub 2006 Nov 27.

Quantitative continuous assay for hyaluronan synthase

Affiliations

Quantitative continuous assay for hyaluronan synthase

Joanne C Krupa et al. Anal Biochem. .

Abstract

A rapid, continuous, and convenient three-enzyme coupled UV absorption assay was developed to quantitate the glucuronic acid and N-acetylglucosamine transferase activities of hyaluronan synthase from Pasteurella multocida (PmHAS). Activity was measured by coupling the UDP produced from the PmHAS-catalyzed transfer of UDP-GlcNAc and UDP-GlcUA to a hyaluronic acid tetrasaccharide primer with the oxidation of NADH. Using a fluorescently labeled primer, the products were characterized by gel electrophoresis. Our results show that a truncated soluble form of recombinant PmHAS (residues 1-703) can catalyze the glycosyl transfers in a time- and concentration-dependent manner. The assay can be used to determine kinetic parameters, inhibition constants, and mechanistic aspects of this enzyme. In addition, it can be used to quantify PmHAS during purification of the enzyme from culture media.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representation of the three-enzyme coupled signal decrease assay for PmHAS. PmHAS transfers GlcNAc and GlcUA from UDP-GlcNAc and UDP-GlcUA to the nonreducing end of HA so as to extend the HA chain. The assay relies on coupling the release of UDP produced from Eq. (1) to PEP in the presence of PK (Eq. (2)). Then pyruvate, a by-product of Eq. (2), is reduced to l-lactate with concomitant oxidation of NADH into NAD+ (Eq. (3)). The decrease in NADH absorbance is monitored in a continuous fashion.
Fig. 2
Fig. 2
Detection limit for the signal decrease assay for PmHAS using purified recombinant PmHAS1–703. Data were obtained at near-saturating conditions (4KM, app) of UDP-GlcUA, UDP-GlcNAc, and HA4. Absolute values of the rates are plotted. The standard deviation of repeated values is less than 10%.
Fig. 3
Fig. 3
Structure of the Xuorescent HA primer HA4-ANDA.
Fig. 4
Fig. 4
Fluorophore-assisted carbohydrate electrophoresis. Lane 1 contains 3 nmol of HA4-ANDA and 30 nmol of both UDP-GlcNAc and UDP-GlcUA. Lane 2 contains 3 nmol of HA4-ANDA. Lane 3 contains 3 nmol of HA4-ANDA and 30 nmol of both UDP-GlcNAc and UDP-GlcUA in the presence of non-induced cell lysate. Lane 4 shows the extension of HA4-ANDA on the addition of 3 nmol of HA4-ANDA combined with 30 nmol of both UDP-GlcNAc and UDP-GlcUA in the presence of induced cell lysate. Lane 5 is a repeat of lane 4 except that the elongated HA4-ANDA fragments were not treated with acid or boiled prior to loading on a gel (see Materials and methods). The elongated HA4-ANDA fragment shown in lane 4 was digested with either Streptomyces (lane 6) or bovine testicular HAase (lane 7).
Fig. 5
Fig. 5
Representative Michaelis–Menten plot of rate (abs/min) versus [HA4]. Data were obtained at near-saturating substrate concentrations (≥4KM, app) for UDP-GlcUA and UDP-GlcNAc using the standard assay protocol. Absolute values of the rates are plotted.
Fig. 6
Fig. 6
Representative inhibition plot for UDP-Glc obtained at 0.5KM, app for each UDP-GlcUA, UDP-GlcNAc, and HA4. Data were obtained using the standard assay protocol.
Fig. 7
Fig. 7
Representative Dixon plot of 1/rate versus [UDP-Glc]. Data were obtained at 0.5KM, app for each UDP-GlcUA and HA4 while working at near-saturating conditions for UDP-GlcNAc (4KM, app). Absolute values of the rates are plotted.

Similar articles

Cited by

References

    1. Toyokawa K, Harayama H, Miyake M. Exogenous hyaluronic acid enhances porcine parthenogenetic embryo development in vitro possibly mediated by CD44. Theriogenology. 2005;64:378–392. - PubMed
    1. Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inXammation. FASEB J. 2006;20:9–22. - PubMed
    1. Price RD, Myers S, Leigh IM, Navsaria HA. The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am. J. Clin. Dermatol. 2005;6:393–402. - PubMed
    1. Yabushita H, Kishida T, Fusano K, Kanyama K, Zhuo L, Itano N, Kimata K, Noguchi MY. Role of hyaluronan and hyaluronan synthase in endometrial cancer. Oncol. Rep. 2005;13:1101–1105. - PubMed
    1. Adamia S, Maxwell CA, Pilarski LM. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005;5:3–14. - PubMed

Publication types

MeSH terms

LinkOut - more resources